Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 25;211(1):9-10.
doi: 10.1164/rccm.202408-1578ED. Online ahead of print.

Toll-like Receptor 9 in Preclinical Models of Idiopathic Pulmonary Fibrosis

Priyanka Verma  1 , Timothy Hamill  1 , Swati Bhattacharyya  2
Affiliations

Toll-like Receptor 9 in Preclinical Models of Idiopathic Pulmonary Fibrosis

Priyanka Verma et al. Am J Respir Crit Care Med. .
No abstract available

Keywords: fibrosis, lung, IPF, ILD.

PubMed Disclaimer

Comment on

  • doi: 10.1164/rccm.202401-0065OC

References

    1. Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis Nat Rev Dis Primers 2017;3: 1–19. - PubMed
    1. Verma P, Bale S, Varga J, Bhattacharyya S. Molecular mechanisms underlying systemic sclerosis–associated interstitial lung disease and idiopathic pulmonary fibrosis: an update. Curr Treat Options Rheum . 2023;9:221–235.
    1. Karampitsakos T, Woolard T, Bouros D, Tzouvelekis A. Toll-like receptors in the pathogenesis of pulmonary fibrosis. Eur J Pharmacol . 2017;808:35–43. - PubMed
    1. Ren C, Wang Q, Fan S, Mi T, Zhang Z, He D, et al. Toll-like receptor 9 aggravates pulmonary fibrosis by promoting NLRP3-mediated pyroptosis of alveolar epithelial cells. Inflammation . 2024;47:1744–1761. - PubMed
    1. Trujillo G, Meneghin A, Flaherty KR, Sholl LM, Myers JL, Kazerooni EA, et al. TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med . 2010;2:57ra82. - PMC - PubMed

LinkOut - more resources